Time to extubation for lung transplant recipients represents a pragmatic end-point to guide the development of prognostic tests

J Heart Lung Transplant. 2023 Nov;42(11):1515-1517. doi: 10.1016/j.healun.2023.06.019. Epub 2023 Jul 3.

Abstract

The field of transplantation would benefit from the integration of advanced precision medicine techniques. Although predictive tests for lung transplantation require a well-defined clinical end-point, there exists no consensus regarding which outcomes are optimal end-points for these purposes. While many possible candidate end-points exist, we propose that time-to-extubation is an optimal end-point for prognostic tests because of its: clinical relevance; objectiveness; stability over time; and association with healthcare expenditure. Herein, we describe the rationale for this selection and present the limitations of alternative outcomes for this purpose. Using a 72-hour cut-off, time to extubation correlated well with Primary Graft Dysfunction Grade 3, intensive care unit and hospital length of stay, and a greater than 2-fold increase in healthcare cost ratios. Given that time-to-extubation is an objective measure that is readily measured by all lung transplant centers, this metric represents a preferred primary end-point for prognostic tests developed for lung transplantation.

Keywords: costs; end-point selection; lung transplantation; mechanical ventilation; post-transplant outcomes.

MeSH terms

  • Airway Extubation*
  • Humans
  • Length of Stay
  • Lung
  • Lung Transplantation* / methods
  • Prognosis
  • Retrospective Studies
  • Transplant Recipients